Background: Evidence suggests that morbid obesity may be an independent risk factor for adverse outcomes in patients with traumatic injuries. Objectives: In this study, a theoretic analysis using a derivation of the Guyton model of cardiovascular physiology examines the expected impact of obesity on hemodynamic changes in Mean Arterial Pressure (MAP) and Cardiac Output (CO) during Hemorrhagic Shock (HS).
Background
According to recent national estimates, over 78 million adults and 12.5 million children and adolescents in the United States are obese (1) . Despite the remarkable prevalence of obesity in the U.S. and the many known detrimental health effects caused by obesity, there are still a number of mysteries surrounding the effects of obesity on both therapeutic and diagnostic care, particularly in the area of trauma. Previous research has suggested that obese patients may be at greater risk for increased morbidity and mortality, though these findings have not been entirely consistent (2) (3) (4) (5) . There have been many proposed etiologies for the differences in outcomes in obese trauma patients. A recent, retrospective study by Nelson and colleagues found that obese patients were at increased risk for early hypovolemic shock and higher subsequent mortality (6) . They did note, however, that when correcting for Body Mass Index (BMI), obese patients received significantly smaller fluid volumes during the initial resuscitation period, creating an obvious potential confounder (6) . Similarly though, animal studies have demonstrated that obese rats have impaired hemorrhage tolerance compared to their nonobese counterparts (7, 8) .
Noting this compelling, though limited evidence, we sought to further examine the effects of obesity in hemorrhagic shock using a systems analysis approach. Computational modeling is a validated methodology for the evaluation and analysis of clinically relevant questions that might be feasibly difficult to answer (9) (10) (11) . In trauma patients, particularly those with significant hemorrhage, therapeutic treatments are time sensitive, and fully evaluating all potential effects of obesity on cardiovascular physiology could be difficult and potentially complicate resuscitations without preliminary data. Additionally, the modeling and systems analytic approach allows for a more thorough examination of the mechanisms responsible for the observed phenomena. The Guyton model of cardiovascular physiology is a well-studied and previously published means for evaluating circulatory functioning, and the anticipated effects of changes on the cardiovascular system (12) (13) (14) (15) . Continued expansion of the model to over 5000 individual physiological variables also includes integrated functioning of neuroendocrine and metabolic systems in circulatory control. Recent analysis has found that the extended version of the Guyton model is able to accurately predict physiologic responses to hemorrhage (16, 17) .
Objectives
The objective of this study was to perform a theoretic analysis using a derivation of the Guyton model of cardiovascular physiology to evaluate the impact of obesity on expected hemodynamic changes in Mean Arterial Pressure (MAP) and Cardiac Output (CO) during the very early stages (the golden hour of trauma) of acute Hemorrhagic Shock (HS) and examine the possible physiologic mechanisms responsible for these changes.
Patients and Methods
The methods used in this study were those required for a theoretic analysis of the effects of increasing BMI on the global hemodynamics changes during hemorrhage. The analytic procedure involved recreating the physiologic conditions associated with changing BMI for a virtual subject created with the use of a mathematical model of human physiology. In keeping with the national heart, lung, and blood institute's terminology, we considered a BMI of 20 -24.9 mg/kg 2 as normal weight and a BMI of ≥ 30 mg/kg 2 as Grade I obesity (18) . First, the model was validated for the known effect of a BMI of 30 on iliofemoral venous pressures. Then, the relative effect of changing BMI on the outcomes of target cardiovascular parameters (cardiac output and mean arterial between the virtual normal weight and obese subjects. Given that no human or animal subjects were involved in this study, an institutional review was not required.
Computational Platform and Systems Analysis Protocol
The computational methodology used in the systems analysis employs a well-established computer model of human physiology (Guyton/Coleman/Summers model). This model has been developed over the past 30 years and describes the integrative cardiovascular physiologic functioning of a virtual subject (10, 12, 13, 15) . The mathematical package used in the current analysis was a homegrown product developed by one of the authors (Coleman) using C++ as the programming language. This model and methodology, which previously have been used in numerous studies, are intended to provide a more detailed understanding of the physiologic mechanisms involved in common clinical conditions (11, 13-15, 19, 20) . Further, several versions of this model have been previously demonstrated to accurately predict hemodynamic changes seen during hypotensive states (11, 17, 20) . The model has been specifically validated previously for hemorrhagic states in a published study in which humans were placed in a simulated shock state by a standard lower body negative pressure technique (17) . In this paper the model is further validated for the state of obesity as described below. While it is not expected that there will be absolute agreement between the model output and experimental findings, there should be definite measurable criteria by which to judge the validity of the model (9, 17) . Specific methods and criteria previously described in the literature were used in the validation process of the computational platform and are presented and referenced in our previous papers (9, 17) . The overall dynamic performance of the model was quantified by determination of the median performance error (MDPE = median [PE] over all data points as % of measured where PE = difference between measured and predicted values). MDPE has been considered as the measure of the bias and inaccuracy between the model's predictions and the corresponding experimental observations. This measure has been employed in the validation of algorithms used in insulin pumps and drug delivery systems in which precision is of the utmost of clinical importance (17) . A commonly considered error margin of 5% was chosen a priori for this study.
This evaluation suggests that the model can be used as a platform for the theoretical analysis of such shock states. The model contains numerous parameters that describe the detailed interactions of systemic, organ, and tissue cellular physiology and metabolism using basic physical principles and established biologic relationships. The model's structure not only incorporates the cardiovascular and neurogenic physiologic responses to changes in pressures, flows, and hydraulics within the circulatory system, but also incorporates the utilization and mass balance fluctuations of metabolic substrates. The details of this model structure are beyond the scope of the current paper though they have been described in previous publications (12, 13) .
The systems analytic procedure using the computational platform involves recreating the clinical scenario for virtual obese and nonobese subjects within an In Silico environment (17, 18) . We performed a series of simulation studies in which the states of truncal obesity and nonobesity were instantiated within the model parameter sets with their concomitant impacts on vascular, metabolic, and endocrine components. Two of the major physiologic elements included in this state change were a shift in the insulin/glucagon axis secondary to changes in receptor sensitivities and an increase in the intraabdominal pressures from a normal range of 5 mmHg in the nonobese to a level of 15 mmHg in the obese (21) (22) (23) (24) (25) (26) . Both of these pathophysiologic changes have been documented in clinical studies in human subjects. The computer simulation was allowed to run until the model system blood pressure reached a steady state. The determined values for the cardiac outputs and mean arterial pressures, as driving hemodynamic components of shock, were then compared for the virtual obese and nonobese individuals.
A clearer understanding of the basic model functioning and dynamics can be obtained using a graphical analysis of cardiac output control as was developed by Dr. Arthur C. Guyton, one of the progenitors of the current model ( Figure 1 ). The cascade of hemodynamic and physiologic regulatory responses seen during an acute hemorrhagic event can be succinctly illustrated from an analysis of a classic Guyton diagram of the control of cardiac output and venous return. The hemodynamics of blood flow in the circulation can be considered dynamically as an intersection between the curves for cardiac output as determined by the Starling functional relationship to atrial pressures and cardiac filling and the impact of those same factors for influencing venous return. The equilibrium intersection of those curves (point A) determines the blood flow. With hemorrhage, the loss of volume in the circulation immediately results in a concurrent reduction in the Mean Circulatory Filling Pressure (MCFP) which results in a loss of drive for venous return and cardiac filling. This is depicted by a shift in the venous return curve to the left (#1) and a new equilibrium (point B). The reduction in venous return and subsequent diminished cardiac output elicits a counter regulatory acute response of increase neurohormonal output including sympathetic drive, norepinephrine, epinephrine, renin-angiotensin activation, and vasopressin release. Short-term and longterm arterial pressure control mechanisms are also in play within the model including vascular autoregulation and stress-relaxation responses. These are all demonstrated by a shift in the venous return curve to the right (#2) with a new equilibrium maintaining flow under stressed conditions (point C). If cardiac functions begin to diminished under a sustained stressed without timely blood volume resuscitation (#3), then flow will also begin to deteriorate especially if the hemorrhage is ongoing and there is further loss in venous return (Points D to E). A vicious cycle can ensue with further suppression of cardiac function, diminished flow and eventual irreversible circulatory collapse. These physiological dynamics are all central to the functioning of the model. The equilibrium point (A) defines the steady state cardiac output at a specific atrial pressure. The venous return (and cardiac output) becomes zero when the atrial pressure equals the MCFP. With the initial hemorrhage the MCFP is reduced and the venous return curve shifts to the left (1) to form a new equilibrium point (B) with reduced cardiac output. Neurohormonal responses attempt to bring the curve back to the right (2) to achieve a stable equilibrium point (C). If the hemorrhaged state persists without resuscitation then a depression of the cardiac starling curve can ensue (3) and lower cardiac output again. If the hemorrhage progresses a vicious cycle can result in a shock state with a low cardiac output and low atrial pressure (E).
Model Validation for Obesity
While there has been extensive validation and documentation of the basic computational model used in this study, to assure credibility in this context, the relevant elements of the model predictions for the obese patient were compared to experimental data from the literature. Although it is unrealistic to expect a generalized computational model to exactly reproduce the experimental results of select study participants, the observed results of these baseline simulations should accurately reflect the direction and degree of expected physiologic changes as set by standard methods used for validations of similar analyses (9-11). The target simulation experiment used in this validation differentiated the obese from nonobese subject while tracking the changes in venous pressures distal to the vena cava bifurcation.
1. According to literature sources, the distal inferior vena cava pressure increases by about 125% of baseline values when the abdominal pressure of a normal individual is increased through abdominal cuff compression methods to 20 mmHg (25) . In the simulation, the venous pressure increases by 108% with the same increase in external abdominal pressure which is a 17% difference.
2. Experimental evidence indicates that morbidly obese individuals with estimated intra-abdominal pressures of about 14 mmHg were found to have femoral venous pressures of about 15 mmHg (26). In the simulation, the pressure rises to 14 mmHg with the same increase in abdominal pressure, which represents only a 1% difference.
Results
During hemorrhage simulation, a moderate increase in the BMI was noted to affect both CO and MAP. The virtual obese subject had a 31% decrease in CO and a 23% decrease in MAP during the class II hemorrhage simulation, while the normal weight patient had only a 22% and 16% decrease in CO and MAP, respectively. The virtual obese subject had a 42% greater fall in CO than the normal weight virtual patient, and a 44% greater fall in MAP than the normal weight virtual patient (Figures 2 and 3) . To evaluate the etiology of these effects, a systems analysis of the model was performed. This revealed that the critical dominant mechanism for these hemodynamic differences was an increase in the resistance to venous return resulting from an increase in intra-abdominal pressure due to obesity.
Discussion
In this study of the theoretical effects of obesity in hemorrhagic shock, we found that obese patients are at higher risk for hemodynamic instability with decreased tolerance to volume loss in trauma. These findings could have important clinical practice implications for the management of these patients. As previously mentioned, many studies have found that obese patients are at increased risk for higher morbidity and mortality (2) (3) (4) 27) .
Additionally, recent research has suggested that obese patients may be at higher risk for early hypovolemic shock, but noted that this could be due to relative underresuscitation when correcting for BMI (6) .
Our results expand these findings and suggest a physiological source for impaired hemorrhage tolerance in obese individuals due to increased intra-abdominal pressures which in turn increased resistances to venous return. This finding is significant not only in identifying potentially high risk patients, but also by identifying potential avenues for treatment interventions, which could be effective in preventing sustained shock and consequently decreasing morbidity and mortality. For example, in trauma resuscitations in pregnant patients, a left lateral tilt is recommended to improve cardiac output, due to the increased pressure on the venocaval system from the gravid uterus (28, 29) . Extrapolating from trauma in pregnancy, perhaps simple repositioning of the obese patient could decrease intraabdominal pressures and increase venous return, thereby improving cardiac output. However, unlike our previous study that examined the impact of a uniformly growing gravid uterus on hemorrhagic shock states, a condition of obesity is less homogenous and the influence on the intra-abdominal pressure less readily tracked with changes in size or weight (11) . Therefore, a single weight point signifying the lower end of the definition of obesity (BMI 30) was chosen for the current analysis. Likewise, in the pregnancy study we were able to clearly examine the effects of initiating a tilt and gravitational unloading of the gravid uterus on venous return because of its consistent location and influence of a specific area of the vena cava. A larger finite element model would be required to truly examine the impact of the broader regional changes in adipose tissues and organs such as the liver on the abdominal vasculature which is currently beyond the scope of our model.
There is some evidence suggesting that obese patients are at high risk for hypovolemic shock simply due to relative under-resuscitation may also be reflective of this physiologic derangement (6) . Some insight into the reasons for this increased risk in the obese trauma patient may be found in the results of our systems analysis. Venous return is a function of the MCFP and resistance to venous return (12) . If the resistance is increased this will necessitate an increase in the MCFP to normalize the venous return and cardiac output. This might inform our treatment strategy. A relatively more aggressive fluid resuscitation may be required in the obese as compared to normal weight subjects in order to increase the MCFP and overcome the increased resistance to venous return.
While the focus of this investigation was on the basic plumbing of the hemodynamics in the very early stages of hemorrhagic shock (the golden hour), the model is also capable of exploring metabolic and hormonal responses. The impact of the shifting insulin/glucagon axis on blood pressure is thought to be due to its impacts on renal functioning, sodium balance, and vascular reactiv-ity. The possible quantitative role of this axis in arterial pressure control was described through use of a mathematical model in an earlier publication (30) . These factors are inherent in the current model and are a part of the 5000 interacting variables. In the acute period (golden hour of trauma) these factors play less of a dominant role as compared to the basic physics of the circulatory hemodynamics and are more relevant during the more protracted timeframes of this type of shock. Heart rate is one of the variables that could have been very easily included in this analysis, but in these early stages it may be less informative due to fluctuating stress related influences that are difficult to model. Therefore there was concern that any simulation driven conclusions about heart rate changes might be misleading.
Further, we found that a modest increase in BMI imparted notable effects on CO and MAP. We compared a virtual normal weight and obese patient in this analysis, with the obese patient defined as a BMI of 30 mg/kg 2 . The effects of grade II or III obesity (a BMI of 35 -39.9 mg/kg 2 and ≥ 40 mg/kg 2 , respectively) could potentially impart even more significant deleterious effects on CO and MAP (18) . In this study, however, we used a more conservative cutoff to determine if even moderate increases in BMI could potentially impact physiological response.
The limitations of a computational, theoretical method are evident and involve the inherent assumptions of the mathematical model from both a physiologic and an anatomic position. However, the validation comparisons are considered within the reasonable range of error for this type of biologic modeling (31, 32) . Further, although more accurate results are possible through manipulation of the mathematics of the model's parameters and structure, this process would not be true to the experimental literature upon which the model was constructed, potentially leading to conclusion with tenuous foundations. The current model has limitations in its degree of anatomic compartmentalization beyond the level of the major organ systems. While this probably does not have a major differential impact on the hydraulics and hemodynamic of acute shock, it may impact the some of the time constants for metabolic exchanges such as oxygen and glucose in this timeframe. However, the limitations of such variables are not evident in the outcomes as compared to the validation measures (17) . There are also limitations in the immunologic responses embedded in this model but those factors probably have less impact on our central hypothesis that examines the acute phase. The hormonal and neurologic responses are considerably robust in this model and while there is always room for additional detail, we believe the current features are adequate for the question at hand.
While our simulations suggest that there are substantial differences in the responses of obese and nonobese hemorrhaged patients, there are no statistical determinations to establish the significance of these differences. Unlike clinical studies, in which each point describes a mean outcome for the populations with an associated standard deviation, In Silico studies use methods that are deterministic and characterize the outcomes for a single individual who is representative of the whole population. This approach is considered valid, however, because the separate components of the model's physiology are constructed from population means (11) . It may be possible to incorporate the specifics of an individual's physiology into the model so that it can be used for real-time clinical predictions.
The simulations are for only one simple case and do not cover the dynamic spectrum of and ranges of possible obesity and hemorrhage. This approach might be considered to limit the usefulness of the results. We wanted to evaluate the idea at the lowest level of what is clinically identified as obesity and at a modest level of hemorrhage. It was thought that morbid obesity and severe hemorrhage would amplify the results and be misleading. In addition, the occurrence of those conditions combined (morbid obesity and severe hemorrhage) are much less common and therefore would have limited practical clinical relevance.
In simulated Class II hemorrhagic shock, we found that obese subjects had greater decreases in CO and MAP compared to their normal weight counterparts, placing them at higher risk for hemodynamic instability and shock. In this analysis, the primary mechanism for this difference was an increase in intra-abdominal pressure due to obesity, which resulted in increased resistances to venous return. After establishing the theoretical consistency of this primary hypothesis of the impact of obesity on shock in hemorrhage and identifying a probable mechanism through the systems analysis approach, we would hope that future investigations might examine some specifics of time dependent dynamics, derangements of metabolism, treatment schemes and even outcomes in both computer simulations and actual live clinical studies.
